Immune Mediators Important for a Protective Secondary Response to Babesia microti
Pathogens · 2024
DOI: 10.3390/pathogens13020123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Joseph Conti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA. Hauptthemen laut MEDLINE: Babesia microti, Babesiosis, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, Department of Defence, NIH NIAID.
Abstract (Originalsprache)
Babesia microti (B. microti) is a tick-transmitted protozoan parasite that invades red blood cells. It is the primary cause of human babesiosis in the US. The severity of babesiosis caused by B. microti infection can range from asymptomatic to fatal. Risk factors for severe disease include general immune suppression, advanced age (>50) and lack of a spleen. However, severe disease can occur in the absence of any known risk factors. The degree to which tick-transmitted B. microti infection confers protection from subsequent exposure is largely unexplored. This is an important question as both the prevalence and geographic range of tick-transmitted B. microti infection continues to increase and individuals in endemic regions may have multiple exposures over their lifetime. In the current study we used a mouse model to evaluate the degree to which primary infection with B. microti protected against secondary challenge with the same parasite strain. We show that CD4 T cells, and to a lesser extent B cells, contribute to protection. However, mice exhibited significant protection from secondary parasite challenge even in the absence of either CD4 T cells or B cells. The protection mediated by CD4 T cells did not depend on their production of IFN-γ as mice with a targeted gene deletion for the IFN-γ receptor remained fully protected against secondary challenge. Other factors including inducible nitric oxide synthase (iNOS) and the adaptor protein MyD88, important for toll-like receptors, IL-18 and IL-1 signaling, were not important for protection against primary or secondary challenge with B. microti. Thus, our study shows that resolution of primary infection with B. microti results in robust protection against secondary challenge with parasites, at least in the short term. Further studies are needed to evaluate the length of protection and the degree to which protection is impacted by parasite heterogeneity. Although we show an important role for CD4 T cells in protection against secondary challenge, our results suggest that no single aspect of the immune system is solely responsible for adequate protection against secondary challenge with B. microti.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.
- Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha 2713, Qatar.
ORCID-Profile: Paul M Arnaboldi, Sini Skariah
Förderung
- National Institute of Allergy and Infectious Diseases
- Department of Defence
- NIH NIAID
- Department of Defense
Zitieren
APA
Conti, J., Gagliardi, T., Arnaboldi, P. M., Hale, S. J., Skariah, S., Sultan, A. A., & Mordue, D. G. (2024). Immune Mediators Important for a Protective Secondary Response to Babesia microti. Pathogens. https://doi.org/10.3390/pathogens13020123
Vancouver
Conti J, Gagliardi T, Arnaboldi PM, Hale SJ, Skariah S, Sultan AA, et al. Immune Mediators Important for a Protective Secondary Response to Babesia microti. Pathogens. 2024. doi:10.3390/pathogens13020123
BibTeX
@article{Conti2024,
author = {Conti, Joseph and Gagliardi, Thomas and Arnaboldi, Paul M and Hale, Synthia J and Skariah, Sini and Sultan, Ali A and Mordue, Dana G},
title = {Immune Mediators Important for a Protective Secondary Response to Babesia microti},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13020123}
}
EUVIMED